153 related articles for article (PubMed ID: 15448024)
1. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
2. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
3. Update on Biomarkers in Renal Cell Carcinoma.
Saliby RM; Saad E; Kashima S; Schoenfeld DA; Braun DA
Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430734. PubMed ID: 38207251
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma.
Cairns P
Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.
Wu Y; Kwon YS; Labib M; Foran DJ; Singer EA
Dis Markers; 2015; 2015():648495. PubMed ID: 26609190
[TBL] [Abstract][Full Text] [Related]
6. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.
Boer JM; Huber WK; Sültmann H; Wilmer F; von Heydebreck A; Haas S; Korn B; Gunawan B; Vente A; Füzesi L; Vingron M; Poustka A
Genome Res; 2001 Nov; 11(11):1861-70. PubMed ID: 11691851
[TBL] [Abstract][Full Text] [Related]
7. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
[TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
Knudsen JE; Rich JM; Ma R
Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
[TBL] [Abstract][Full Text] [Related]
9. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment.
Phan JH; Moffitt RA; Stokes TH; Liu J; Young AN; Nie S; Wang MD
Trends Biotechnol; 2009 Jun; 27(6):350-8. PubMed ID: 19409634
[TBL] [Abstract][Full Text] [Related]
10. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.
Sharma R; Kannourakis G; Prithviraj P; Ahmed N
Front Med (Lausanne); 2022; 9():766869. PubMed ID: 35775004
[TBL] [Abstract][Full Text] [Related]
11. miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma.
Gong X; Zhao H; Saar M; Peehl DM; Brooks JD
Kidney Cancer; 2019 Aug; 3(2):119-132. PubMed ID: 31763513
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for renal cell carcinoma: The next lap.
Kanesvaran R; Tan MH
J Carcinog; 2014; 13():3. PubMed ID: 24737951
[TBL] [Abstract][Full Text] [Related]
14. Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas.
Park JH; Lee C; Suh JH; Moon KC
Korean J Pathol; 2012 Dec; 46(6):541-7. PubMed ID: 23323104
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for the practical management of renal cell carcinoma.
Lee LS; Tan MH
Nat Rev Urol; 2012 Jan; 9(2):73-84. PubMed ID: 22231290
[TBL] [Abstract][Full Text] [Related]
16. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?
Seliger B; Jasinski S; Dressler SP; Marincola FM; Recktenwald CV; Wang E; Lichtenfels R
J Proteome Res; 2011 Jan; 10(1):191-9. PubMed ID: 21142213
[TBL] [Abstract][Full Text] [Related]
17. RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis.
Park J; Bae E; Lee C; Yoon SS; Chae YS; Ahn KS; Won NH
Tumour Biol; 2010 Dec; 31(6):643-50. PubMed ID: 20820979
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression.
Zhang Z; Wondergem B; Dykema K
Adv Bioinformatics; 2010; 2010():428325. PubMed ID: 20671976
[TBL] [Abstract][Full Text] [Related]
19. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
[TBL] [Abstract][Full Text] [Related]
20. Staging of renal cell carcinoma: Current concepts.
Lam JS; Klatte T; Breda A
Indian J Urol; 2009; 25(4):446-54. PubMed ID: 19955666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
